Abstract:Abstract Background/Aims Patients with connective tissue disease-related interstitial lung disease (CTD-ILD) often receive care from both rheumatologists and respiratory physicians to manage their conditions. As treatment options become increasingly complex with immunosuppressing and antifibrotic agents, there is a growing recognition of the importance of collaborative approaches to ensure accurate diagnosis, aid management decisions and deliver patient-centred care. However, there is currently no agreed optimal model for shared care, leading to significant practice variation. This study aimed to explore the perspectives of rheumatologists and respiratory physicians regarding the benefits and challenges of cross-speciality management in CTD-ILD. A better understanding of this will enhance the development of services and improve patient-centred care. Methods Semi-structured interviews, both face-to-face and virtual, were conducted with 11 respiratory physicians and nine rheumatologists working in Wales, ensuring representation from all health boards. Interview transcripts were analysed using thematic analysis to identify themes. Results Five main themes were identified: navigating complexity and uncertainty, reliance on clinical experience, prioritisation of efficiency, educational and training benefits, and inconsistent access to services for clinicians and patients. Conclusion The complexity of CTD-ILD care, combined with varying levels of physician expertise and a perceived lack of guidelines, presents significant challenges for clinicians. Cross-speciality collaboration is actively sought by physicians and is perceived to enhance patient care by improving efficiency, aiding confidence in decision-making and providing educational benefits to clinicians. However, resource limitations and geographical variations in service access hinder the implementation and development of shared care models. Physicians perceive that patients like being seen in joint clinics; future exploration of patient perspectives and experiences of joint care systems will be crucial to ensure the direction of clinical practice development remains patient-centred. In addition to implementing integrated cross-speciality clinical services, the development of joint respiratory and rheumatology guidelines as well as greater availability of training opportunities would assist physicians in delivering optimal care to patients with CTD-ILD. Disclosure P. Evans: None. K. Hett: None. N. Hutchinson: None. C. Beynon: None.

Special Issue on interstitial lung disease in the setting of rheumatic disorders

Interstitial lung disease in rheumatic diseases: an update of the 2018 review

A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician's Narrative Review

Early detection of interstitial lung disease in rheumatic diseases: A joint statement from the Portuguese Pulmonology Society, the Portuguese Rheumatology Society, and the Portuguese Radiology and Nuclear Medicine Society

Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease

Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review

Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review

Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review

Interdisciplinary Diagnosis and Management of Patients With Interstitial Lung Disease and Connective Tissue Disease

Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?

The interplay between rheumatic diseases and pulmonary health

Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment

The Lung in Rheumatoid Arthritis—Friend or Enemy?

Diffuse lung involvement in rheumatoid arthritis: a respiratory physician's perspective

Rheumatoid arthritis–associated interstitial lung disease: an overview of epidemiology, pathogenesis and management

P129 Interdisciplinary collaboration in the care of patients with connective tissue disease-related interstitial lung disease in Wales: an interview study

[Interstitial lung diseases : From imaging to treatment]

Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis

Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis